Ying Huang
Vice President, Biologics CMC Crescent Biopharma
Seminars
Tuesday 15th September 2026
Enabling Rapid IND Delivery Through Strategic CMC Development of a PD-1/VEGF Bispecific Antibody
2:00 pm
- Accelerating biologics CMC timelines through strategic, risk-based development approaches
- Balancing purification efficiency, manufacturability, and product variant control
- De-risking late-stage development through early product and process understanding
Tuesday 15th September 2026
Group Roundtable Discussions
3:00 pm
- Roundtable discussions are designed to be interactive, discursive deep dives where delegates break into smaller groups to explore a focused topic through candid, peer-led conversation. Each group will exchange experiences, challenges, and practical insights before reconvening to share key takeaways with the wider audience and with the conversation being facilitated by our seminar day leaders.
